4//SEC Filing
EcoR1 Panacea Holdings, LLC 4
Accession 0001213900-20-016762
CIK 0001811063other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:06 PM ET
Size
16.9 KB
Accession
0001213900-20-016762
Insider Transaction Report
Form 4
EcoR1 Panacea Holdings, LLC
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
EcoR1 Capital Fund Qualified, L.P.
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
NODELMAN OLEG
DirectorCEO and Chairman of the Board
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
EcoR1 Capital Fund, L.P.
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
EcoR1 Venture Opportunity Fund, LP
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
EcoR1 Capital, LLC
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
Biotech Opportunity GP, LLC
Director10% Owner
Transactions
- Purchase
Class A common stock
2020-07-06$10.00/sh+390,000$3,900,000→ 390,000 total
Footnotes (2)
- [F1]The reported shares are included within the 390,000 private placement units of the issuer purchased by EcoR1 Panacea Holdings, LLC (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of Class A common stock of the issuer and one-third of one redeemable warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering.
- [F2]The reporting owner, the Sponsor, in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the "General Partners"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein.
Documents
Issuer
Panacea Acquisition Corp
CIK 0001811063
Entity typeother
Related Parties
1- filerCIK 0001816134
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:06 PM ET
- Size
- 16.9 KB